Basit öğe kaydını göster

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

dc.contributor.authorAdalet, Isik
dc.contributor.authorKuyumcu, Serkan
dc.contributor.authorIsik, Goknur
dc.contributor.authorAsoglu, Oktar
dc.contributor.authorTurkmen, Cuneyt
dc.contributor.authorSanli, Yasemin
dc.contributor.authorKapran, Yersu
dc.contributor.authorHas, Duygu
dc.contributor.authorKilic, Leyla
dc.contributor.authorOzkan, Zeynep Gozde
dc.contributor.authorBalik, Emre
dc.date.accessioned2021-03-05T17:58:58Z
dc.date.available2021-03-05T17:58:58Z
dc.date.issued2012
dc.identifier.citationSanli Y., Kuyumcu S., Ozkan Z. G. , Kilic L., Balik E., Turkmen C., Has D., Isik G., Asoglu O., Kapran Y., et al., "The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels", ANNALS OF NUCLEAR MEDICINE, cilt.26, ss.551-558, 2012
dc.identifier.issn0914-7187
dc.identifier.otherav_c828aa26-2e48-4eef-a933-007d478b8322
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/132645
dc.identifier.urihttps://doi.org/10.1007/s12149-012-0609-0
dc.description.abstractTumor recurrence of colorectal cancers (CRC) is generally followed up by analyses of the serum carcinoembryonic antigen (CEA) levels. However, recent evidence suggests that tumor recurrence can also be visualized by 18F-fluoro-deoxyglucose emission tomography/computed tomography (FDG-PET/CT) in patients with normal CEA levels. We retrospectively evaluated the diagnostic performance of FDG-PET/CT in patients with suspected recurrence of CRC by comparing PET/CT performance in patients with normal CEA levels with PET/CT performance in patients with elevated CEA levels.
dc.language.isoeng
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleThe utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
dc.typeMakale
dc.relation.journalANNALS OF NUCLEAR MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume26
dc.identifier.issue7
dc.identifier.startpage551
dc.identifier.endpage558
dc.contributor.firstauthorID26961


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster